Abstract
Introduction: Brachytherapy is a treatment in which sealed radioactive sources are used to deliver high doses of radiation at close distance to the tumor with rapid dose fall-off in the surrounding normal tissue resulting in high therapeutic ratio in oncological disease management. It is effective in palliative treatment for patients with symptoms of hemoptysis and dysnea resulting from endobronchial obstruction.
Conclusion: In spite of the rapid development of external beam radiation therapy brachytherapy continues to remain an important mode of therapy and is often a default treatment when external beam radiation option is limited.
Keywords: Lung cancer, non-small cell, brachytherapy, High Dose Rate (HRD), treatment, tumor.
Current Cancer Therapy Reviews
Title:Lung Cancer Brachytherapy
Volume: 14 Issue: 2
Author(s): Edward Yu*Craig Lewis
Affiliation:
- Department of Oncology, Western University, Ontario, ON N6A-4L6,Canada
Keywords: Lung cancer, non-small cell, brachytherapy, High Dose Rate (HRD), treatment, tumor.
Abstract: Introduction: Brachytherapy is a treatment in which sealed radioactive sources are used to deliver high doses of radiation at close distance to the tumor with rapid dose fall-off in the surrounding normal tissue resulting in high therapeutic ratio in oncological disease management. It is effective in palliative treatment for patients with symptoms of hemoptysis and dysnea resulting from endobronchial obstruction.
Conclusion: In spite of the rapid development of external beam radiation therapy brachytherapy continues to remain an important mode of therapy and is often a default treatment when external beam radiation option is limited.
Export Options
About this article
Cite this article as:
Yu Edward *, Lewis Craig , Lung Cancer Brachytherapy, Current Cancer Therapy Reviews 2018; 14 (2) . https://dx.doi.org/10.2174/1573394714666180208145420
DOI https://dx.doi.org/10.2174/1573394714666180208145420 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics
The thematic issue "Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics" aims to explore cutting-edge developments and innovative strategies in the field of lipid nanoparticle (LNP) technology, particularly focusing on its application in mRNA delivery. This topic has gained unprecedented attention and urgency in the wake of the COVID-19 ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Interaction and Cytotoxic Effects of Hydrophobized Chitosan Nanoparticles on MDA-MB-231, HeLa and Arpe-19 Cell Lines
Current Topics in Medicinal Chemistry Network Pharmacology of Glioblastoma
Current Drug Discovery Technologies Core Functional Sequence of C-terminal GAG-binding Domain Directs Cellular Uptake of IGFBP-3-derived Peptides
Protein & Peptide Letters Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat
Current Drug Targets Putative Breast Tumor Suppressor TACC2 Suppresses the Aggressiveness of Breast Cancer Cells through a PLCγ Pathway
Current Signal Transduction Therapy Glycerophospholipid Synthesis as a Novel Drug Target Against Cancer
Current Molecular Pharmacology Natural Medicine:The Genus Angelica
Current Medicinal Chemistry Gold Nanoparticles-based Bio-Sensing Methods for Tumor-related Biomedical Applications in Bodily Fluids
Current Nanoscience N6-Isopentenyladenosine and its Analogue N6-Benzyladenosine Induce Cell Cycle Arrest and Apoptosis in Bladder Carcinoma T24 Cells
Anti-Cancer Agents in Medicinal Chemistry miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke
MicroRNA Hck Inhibitors as Potential Therapeutic Agents in Cancer and HIV Infection
Current Medicinal Chemistry Some Wild Mushrooms with High Antioxidant Capacity Exhibit Potent Anticancer Activity on Cancer Cells using the Apoptotic and Antimigration Cell Death Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Preclinical and Clinical Efficacy of the Bisphosphonate Ibandronate in Cancer Treatment
Current Clinical Pharmacology Bcl-2-Targeted Antisense Therapy (Oblimersen Sodium): Towards Clinical Reality
Reviews on Recent Clinical Trials Signal Transduction Pathways of Taxanes-Induced Apoptosis
Current Medicinal Chemistry - Anti-Cancer Agents MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53
Anti-Cancer Agents in Medicinal Chemistry Protective Effects of Curcumin against Iron-induced Toxicity
Current Pharmaceutical Biotechnology Androgen Pathway Related Gene Variants and Prostate Cancer Association in Auckland Men
Current Pharmacogenomics and Personalized Medicine Lemongrass (<i>Cymbopogon citratus</i> (D.C.) Stapf) Presents Antitumoral Effect and Improves Chemotherapy Activity in Prostate Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy
Current Cancer Drug Targets